Relationship of MAPH Score with Left Ventricular Apical Thrombus and Adverse Events in Patients with Acute Anterior ST-Elevation Myocardial Infarction

n=185 patients with a first episode of acute anterior ST-elevation myocardial infarction (STEMI) who underwent successful percutaneous coronary intervention (PCI). Exclusions: history of coronary artery disease (CAD), coronary artery bypass graft (CABG), known heart failure with reduced ejection fraction (LVEF ≤ 40%), stroke, chronic kidney disease (eGFR < 30), active infection, known coagulopathy, thrombocytosis, malignancy, moderate heart valve disease, or using oral anticoagulants.

High MAPH score (≥2), a thrombosis-related score calculated from mean platelet volume, age, total protein, and hematocrit

Low MAPH score (<2)

Left ventricular apical thrombus (LVAT) and Major adverse cardiovascular and cerebrovascular events (MACCE) at 12 months follow-up (composite of all-cause death, heart failure, non-fatal myocardial reinfarction, revascularization, and stroke)composite